Swiss National Bank Cuts Position in Bath & Body Works, Inc. (NYSE:BBWI)

Swiss National Bank trimmed its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 34.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 409,300 shares of the company’s stock after selling 219,800 shares during the period. Swiss National Bank’s holdings in Bath & Body Works were worth $15,869,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Golden State Wealth Management LLC purchased a new stake in Bath & Body Works during the 4th quarter worth $26,000. SRS Capital Advisors Inc. lifted its stake in shares of Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after purchasing an additional 329 shares in the last quarter. True Wealth Design LLC boosted its position in shares of Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after buying an additional 1,054 shares during the period. UMB Bank n.a. grew its stake in shares of Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after buying an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC grew its stake in shares of Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after buying an additional 431 shares in the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have weighed in on BBWI shares. Telsey Advisory Group restated an “outperform” rating and issued a $43.00 price target on shares of Bath & Body Works in a report on Thursday, February 27th. Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and raised their price target for the company from $40.00 to $48.00 in a report on Friday, February 28th. Cowen reaffirmed a “buy” rating on shares of Bath & Body Works in a research note on Thursday, February 27th. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $42.00 to $48.00 in a research report on Friday, January 10th. Finally, Piper Sandler lifted their target price on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $45.06.

Read Our Latest Report on BBWI

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $29.97 on Wednesday. The company’s fifty day moving average is $36.10 and its two-hundred day moving average is $33.99. Bath & Body Works, Inc. has a 1-year low of $26.21 and a 1-year high of $52.99. The stock has a market capitalization of $6.49 billion, a price-to-earnings ratio of 7.31, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion for the quarter, compared to analysts’ expectations of $2.78 billion. Sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works announced that its board has initiated a share repurchase plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were paid a dividend of $0.20 per share. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.67%. Bath & Body Works’s payout ratio is currently 21.98%.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Featured Articles

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.